Welcome to our dedicated page for Bwx Technologies SEC filings (Ticker: BWXT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The BWX Technologies, Inc. (NYSE: BWXT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. BWXT files annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K that cover financial performance, material agreements, capital structure changes and governance matters related to its nuclear-focused manufacturing and engineering business.
BWXT’s Form 8-K filings illustrate the range of topics investors can track. Recent 8-Ks have reported quarterly financial results, including revenue and segment performance for Government Operations and Commercial Operations, and have furnished earnings press releases that explain non-GAAP measures such as adjusted EBITDA, non-GAAP earnings per share and free cash flow. Other 8-Ks describe executive leadership changes, such as appointments of senior finance and legal officers, and provide details on material definitive agreements.
Filings also document capital markets transactions. In 2025, BWXT filed an 8-K describing the issuance of 0% Convertible Senior Notes due 2030 under an indenture with a trustee, including the aggregate principal amount, guarantee structure by certain domestic subsidiaries, conversion conditions, maturity date and events of default. Another 8-K discusses the planned private offering of convertible senior notes and expectations regarding a new senior secured revolving credit facility, subject to market conditions and other factors.
Through this page, users can follow BWXT’s official disclosures about its nuclear-related operations, contracts and financial condition. Stock Titan enhances access to these documents with AI-powered summaries that highlight key terms in filings such as 10-K and 10-Q reports, and can help interpret complex sections on topics like segment performance, non-GAAP metrics, convertible notes and covenant structures. The page also links to insider and governance-related information reported in current reports, giving a consolidated view of BWXT’s regulatory record.
BWX Technologies, Inc. SVP & Chief Financial Officer Michael Thomas Fitzgerald exercised employee stock options to acquire 2,826 shares of common stock at $61.70 per share. To satisfy tax obligations, 1,618 shares were withheld at $215.20 per share, a non-market, tax-withholding disposition.
After these compensation-related transactions, he directly holds 6,884 shares of BWX Technologies common stock. The option grant being exercised was part of an award that vests in three equal annual installments beginning February 27, 2024.
BWX Technologies, Inc. reported results from its April 30, 2026 annual meeting of stockholders. Shareholders elected ten directors to one-year terms ending at the 2027 annual meeting, with each nominee receiving substantially more votes for than against.
Stockholders also cast an advisory vote approving 2025 compensation for the company’s named executive officers and ratified the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the year ending December 31, 2026.
Bertsch Jan reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies director Jan Bertsch received a grant of 762 restricted stock units (RSUs) under the company’s 2020 Omnibus Incentive Plan. Each RSU represents a contingent right to one share of BWXT common stock and vested immediately as part of her board compensation.
Bertsch elected to defer delivery of the shares. According to her deferral election, the vested shares will be delivered in a single lump sum two years after her service on the Board of Directors ends, turning this equity grant into longer-term deferred compensation.
Burbach Gerhard F reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies, Inc. director Gerhard F. Burbach received a grant of 762 restricted stock units as equity compensation under the company’s 2020 Omnibus Incentive Plan. Each unit represents a contingent right to receive one share of BWXT common stock.
The RSUs vested immediately, but Burbach elected to defer receipt of the underlying shares. Under his deferral election, the vested shares will be delivered in one lump sum two years after his service on the Board of Directors ends.
JASKA JAMES M reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies, Inc. director James M. Jaska received a grant of 762 restricted stock units under the company’s 2020 Omnibus Incentive Plan. Each unit represents a contingent right to one share of BWXT common stock. The RSUs vested immediately, but he elected to defer share delivery into five annual installments after his board service ends.
BWX Technologies, Inc. director Kenneth J. Krieg reported compensation-related equity activity involving restricted stock units and common shares. He was granted 762 restricted stock units (RSUs) under the company's 2020 Omnibus Incentive Plan, with each RSU representing a contingent right to receive one share of BWXT common stock.
The filing shows 762 RSUs vesting immediately and converting into 762 shares of common stock, with no open-market purchases or sales. Following these transactions, Krieg directly holds 2,227 shares of BWXT common stock, reflecting routine director equity compensation rather than discretionary trading.
Melvin Leland D reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies, Inc. director Melvin Leland D received a grant of 762 restricted stock units (RSUs) on April 30, 2026 under the company’s 2020 Omnibus Incentive Plan. Each RSU represents a contingent right to one share of BWXT common stock.
The RSUs vested immediately, but the director elected to defer receipt of the underlying shares. According to his deferral election, the vested shares will be delivered in five annual installments after his service on the Board of Directors ends. Following this grant, he holds 762 RSUs directly.
BWX Technologies director Barbara A. Niland reported routine equity compensation activity. She exercised 762 restricted stock units (RSUs), receiving an equal number of BWXT common shares, and these RSUs vested immediately under the company’s 2020 Omnibus Incentive Plan.
On the same date, she was granted a new award of 762 RSUs, each representing a contingent right to one share of common stock. Following these transactions, she directly owns 21,858 shares of common stock, reflecting increased direct equity exposure without any reported open‑market sales.
PIASECKI NICOLE WEYERHAEUSER reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies director Nicole Weyerhaeuser Piasecki received a grant of 762 restricted stock units (RSUs) linked to BWXT common stock as equity compensation. The RSUs vested immediately, but she elected to defer receipt of the underlying shares.
Under her deferral election, the vested shares will be delivered in five annual installments, starting one year after her service on the Board of Directors ends. Following this grant, she holds 762 RSUs directly, each representing a contingent right to receive one BWXT common share.
BWX Technologies, Inc. reported solid growth for the quarter ended March 31, 2026, with revenues of $860.2 million, up from $682.3 million a year earlier, and net income of $91.2 million. Diluted earnings per share rose to $0.99 from $0.82.
Government Operations revenue increased to $577.9 million, while Commercial Operations more than doubled to $283.6 million, driven largely by the 2025 acquisition of Kinectrics and higher inspection, maintenance and manufacturing activity. Operating income improved to $106.7 million, with Commercial margins expanding.
Cash provided by operating activities strengthened to $92.6 million, and cash and restricted cash totaled $520.3 million against long‑term debt of about $2.0 billion. Backlog reached $8.65 billion, and the company plans to acquire Precision Components Group to further expand U.S. commercial nuclear manufacturing capacity.